Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study

医学 支气管扩张 慢性阻塞性肺病 抗生素 痰 内科学 观察研究 回顾性队列研究 肺病 痰培养 队列研究 肺 肺结核 病理 微生物学 生物
作者
David de la Rosa,Miguel Ángel Martínez‐García,Esther Barreiro,Eva Tabernero Huguet,Roser Costa Sola,Marta María García Clemente,Nuria Celorrio,Laura Rodríguez-Pons,Carmen Calero Acuña,Juan Luis Rodríguez Hermosa,Rafael Golpe,Raquel Dacal Quintas,Silvia Sánchez-Cuéllar,Irene Torres Arroyo,Marina Blanco‐Aparicio,Virginia Almadana Pacheco,Marc Miravitlles,Annie Navarro,Xuejie Wang,Alicia Marín
出处
期刊:Archivos De Bronconeumologia [Elsevier BV]
卷期号:58 (1): 11-21 被引量:44
标识
DOI:10.1016/j.arbres.2021.03.009
摘要

We aimed to describe the effectiveness and safety of inhaled antibiotics in chronic obstructive pulmonary disease (COPD) patients, as well as the patient profile in which they are usually prescribed and the patient groups that can most benefit from this treatment.Multicentre retrospective observational cohort study in COPD patients who had received ≥1 dose of inhaled antibiotics in the last 5 years. Clinical data from the two years prior to and subsequent to the start of the treatment were compared.COPD exacerbations.side effects, symptomatology (sputum purulence, dyspnoea), microbiological profile and pathogen eradication.Of 693 COPD patients analyzed (aged 74.1; 86.3% men; mean FEV1=43.7%), 71.7% had bronchiectasis and 46.6% presented chronic bronchial infection (CBI) by Pseudomonas aeruginosa (PA). After 1 year of treatment with inhaled antibiotics, there was a significant decrease in the number of exacerbations (-33.3%; P<.001), hospital admissions (-33.3%; P<.001) and hospitalization days (-26.2%; P=.003). We found no difference in effectiveness between patients with or without associated bronchiectasis. Positive patient outcomes were more pronounced in PA-eradicated patients. We found a significant reduction in daily expectoration (-33.1%; P=.024), mucopurulent/purulent sputum (-53.9%; P<.001), isolation of any potentially pathogenic microorganisms (PPM) (-16.7%; P<.001), CBI by any PPM (-37.4%; P<.001) and CBI by PA (-49.8%; P<.001). CBI by any PPM and ≥three previous exacerbations were associated with a better treatment response. 25.4% of patients presented non-severe side-effects, the most frequent of these being bronchospasm (10.5%), dyspnoea (8.8%) and cough (1.7%).In COPD patients with multiple exacerbations and/or CBI by any PPM (especially PA), inhaled antibiotics appear to be an effective and safe treatment, regardless of the presence of bronchiectasis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
日薪月亿发布了新的文献求助10
刚刚
完美世界的应助被Han采纳,获得10
刚刚
1秒前
zhu完成签到,获得积分10
1秒前
大南方完成签到,获得积分10
1秒前
充电宝的应助被坚定蘑菇采纳,获得10
1秒前
SciGPT的应助被椰子鸡采纳,获得10
2秒前
英俊的铭的应助被典雅的羿采纳,获得10
2秒前
2秒前
零点起步完成签到,获得积分10
2秒前
哆哆完成签到,获得积分10
2秒前
王一生完成签到,获得积分0
2秒前
王亚奇的应助被zzz采纳,获得10
3秒前
邱半仙发布了新的文献求助10
3秒前
3秒前
时尚发夹完成签到,获得积分10
4秒前
勤劳元瑶完成签到,获得积分10
4秒前
oldhope完成签到,获得积分10
5秒前
闪闪芹菜完成签到,获得积分10
5秒前
66666完成签到 ,获得积分10
5秒前
TCG完成签到,获得积分10
5秒前
会飞的猪完成签到,获得积分10
7秒前
7秒前
小马甲的应助被宋相甫采纳,获得10
7秒前
zhuchenglu发布了新的文献求助10
7秒前
7秒前
且行丶且努力完成签到,获得积分10
7秒前
8秒前
邱半仙完成签到,获得积分10
8秒前
8秒前
郭刚发布了新的文献求助10
8秒前
8秒前
觞酌的应助被安静静静静采纳,获得10
9秒前
10秒前
鳄鱼蛋完成签到,获得积分10
11秒前
学林书屋发布了新的文献求助10
11秒前
12秒前
Syanx_8发布了新的文献求助10
12秒前
JXY189发布了新的文献求助10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186480
求助须知:如何正确求助?哪些是违规求助? 9574861
关于积分的说明 21838499
捐赠科研通 7784154
什么是DOI,文献DOI怎么找? 3434775
关于科研通互助平台的介绍 2559164
邀请新用户注册赠送积分活动 2481565